Related Experiment Video
Updated: Apr 1, 2026

Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis
Published on: May 12, 2020
Nocardia asteroides Keratitis Resistant to Amikacin
Ravi Patel1, Adam Sise, Zaina Al-Mohtaseb
1*Department of Ophthalmology, Penn State Hershey Medical Center, Hershey, PA; †Bascom Palmer Eye Institute, University of Miami, Miami, FL; and ‡Cullen Eye Institute, Baylor College of Medicine, Houston, TX.
Nocardia keratitis can be resistant to standard treatments like amikacin. This study highlights two cases where alternative therapies, such as trimethoprim-sulfamethoxazole or tobramycin, were necessary for successful Nocardia keratitis treatment.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Microbiology
Background:
- Nocardia keratitis is an uncommon ocular infection.
- Standard treatment protocols exist but may not be effective in all cases.
Observation:
- Two cases of Nocardia keratitis are presented.
- One patient initially received moxifloxacin, then compounded amikacin, and finally trimethoprim-sulfamethoxazole for resolution.
- Another patient with Nocardia asteroides keratitis resistant to amikacin and imipenem was treated with topical tobramycin.
Findings:
- Nocardia keratitis demonstrated resistance to topical compounded amikacin in both cases.
- Trimethoprim-sulfamethoxazole and tobramycin proved effective in resolving the infections.
- Drug sensitivity testing is crucial for guiding treatment in resistant Nocardia keratitis.
Implications:
- Atypical Nocardia keratitis cases necessitate close patient monitoring and potential adjustments to antimicrobial therapy.
- Standard management algorithms may need to be adapted based on individual Nocardia species and drug resistance patterns.
- Prompt identification and susceptibility testing are vital for successful outcomes in challenging Nocardia keratitis cases.
Related Concept Videos
Ophthalmic Drug Delivery Systems
Angle Closure Glaucoma: Treatment
Antifungal Agents
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

